Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 12.8

Adjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,931 91.7% 0.5% 2,931 81.7% 0.7% 7,948 50.6% 0.8% 12,650 24.6% 0.8%
Lung Diagnosis Group Group A: Obstructive Lung Disease 1,046 93.1% 1.7% 1,046 84.6% 3.4% 3,275 45.0% 3.5% 5,871 18.0% 2.3%
Group B: Pulmonary Vascular Disease 124 84.8% 4.6% 124 79.1% 5.8% 336 47.9% 5.1% 576 34.5% 4.0%
Group C: Cystic Fibrosis or Immunodef. Disorders 414 93.2% 2.2% 414 80.0% 5.2% 1,192 39.6% 4.2% 1,924 23.9% 3.0%
Group D: Restrictive Lung Disease 1,271 90.8% 2.5% 1,271 79.9% 4.9% 2,955 58.9% 3.6% 3,948 31.5% 3.3%
Group E: Age Less Than 12 27 87.7% 9.4% 27 70.5% 15.1% 99 46.3% 8.2% 189 31.1% 6.4%
Other Diagnosis 49 90.6% 4.5% 49 88.7% 5.0% 91 55.2% 8.2% 142 39.0% 6.6%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.